So what is leadership? I believe leadership consists of three components: commitment, integrity, and respect.
The U.S. regulatory landscape will continue to evolve in 2018, potentially adding complexity and compliance challenges to the life sciences industry. Recent changes are being driven by nationwide concerns with prescription drug abuse, which is prompting many states to enforce new mandates and programs regarding drug practices.
Two thirds, or 67 percent, of respondents have encountered lower turnover from direct hire sales reps as opposed to CSO reps, according to a recent survey of executives by Best Practices LLC.
As the landscape for pharmaceutical marketing continues to evolve, multi-channel marketers have been investigating opportunities to advertise their products and services, and provide clinical decision support information within electronic health records (EHRs). For the first time, healthcare marketers can impact provider-patient interactions by delivering messages directly at the point of care. EHRs have over 90 percent adoption with healthcare professionals (HCPs) in the U.S., while certain practice specialties reach nearly ubiquitous (99 percent) adoption, thereby creating an exceptional opportunity not to be missed!
Steve Sabus was named general manager of Astellas Pharma Canada (APCA), effective April 1, 2018. In his new role, he will lead business operations in the country.
Uwe Röhrhoff was named CEO of Perrigo Company following the retirement of John T. Hendrickson.
Timothy Whitten has become president of Taiho Oncology Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co. Ltd. (Japan).
Christopher O’Brien, M.D., chief medical officer of Neurocrine Biosciences Inc., retired in February 2018 after a transition period with his successor.
Shaun Urban was named president of the Inception Companies.
Wayne Swanton was promoted to executive VP, Global Operations, at Allergan Plc following notification that Rob Stewart, executive VP and chief operating officer, intended to leave Allergan to become president and CEO of Amneal Pharmaceuticals.
